Zusammenfassung
Das Mikrobiom ist hinsichtlich seiner physiologischen und pathophysiologischen Relevanz im letzten Jahrzehnt immer mehr in den Fokus der Forschung gerückt. Erkenntnisgewinne über die Funktionsweise unseres Mikrobioms verdeutlichen dessen Einfluss auf den Metabolismus. Ebenso werden die Wechselwirkungen mit der Entstehung des metabolischen Syndroms offensichtlich, gleichzeitig entstehen aber neue Fragen: Wird das Mikrobiom dysbiotisch, bevor oder nachdem es zu einem pathologischen Stoffwechsel gekommen ist? Gibt es Möglichkeiten, das Darmmikrobiom zur Therapie des metabolischen Syndroms oder seiner Folgeerkrankungen zu nutzen? Ziel dieses Übersichtsbeitrags ist, jenseits des Modebegriffs „Mikrobiom“ über aktuelle Forschungsansätze zu berichten, die auch für den praktisch tätigen Internisten relevant sind.
Abstract
The microbiome has become recognized as a critical player in the understanding of human physiology and pathophysiology, especially with regard to the metabolic syndrome. While recent findings emphasize the impact of the microbiome on metabolic health, new questions simultaneously arise: Is there a dysbiotic microbiome before the onset of metabolic disorders or is dysbiosis caused by a deranged metabolism? Furthermore, are there opportunities to employ the microbiome as a tool for novel treatment strategies in patients with metabolic syndrome? The intention of this review article is to describe the fashionable term “microbiome” beyond its current research approaches, which will be relevant to the practicing internist.
Literatur
Blaser MJ (2017) The theory of disappearing microbiota and the epidemics of chronic diseases. Nat Rev Immunol 17:461–463
Boers SA, Jansen R, Hays JP (2019) Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis 38:1059–1070
Bolnick HJ, Bui AL, Bulchis A et al (2020) Health-care spending attributable to modifiable risk factors in the USA: an economic attribution analysis. Lancet Public Health 5:e525–e535
Bortolin RC, Vargas AR, Gasparotto J et al (2018) A new animal diet based on human western diet is a robust diet-induced obesity model: comparison to high-fat and cafeteria diets in term of metabolic and gut microbiota disruption. Int J Obes (Lond) 42:525–534
Breton J, Tennoune N, Lucas N et al (2016) Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab 23:324–334
Carmody RN, Gerber GK, Luevano JM Jr. et al (2015) Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17:72–84
Chassaing B, Gewirtz AT (2014) Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 42:49–53
Cox LM, Yamanishi S, Sohn J et al (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705–721
David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–563
Depommier C, Everard A, Druart C et al (2019) Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25:1096–1103
Fahed G, Aoun L, Bou Zerdan M et al (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. https://doi.org/10.3390/ijms23020786
Ferretti P, Pasolli E, Tett A et al (2018) Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host Microbe 24:133–145.e5
Franck M, de Toro-Martín J, Vohl M‑C (2022) Eco-evolutionary dynamics of the human-gut microbiota symbiosis in a changing nutritional environment. Evol Biol 49:255–264
Funabashi M, Grove TL, Wang M et al (2020) A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582:566–570
Gomez De Aguero M, Ganal-Vonarburg SC, Fuhrer T et al (2016) The maternal microbiota drives early postnatal innate immune development. Science 351:1296–1302
Goryakin Y, Thiebaut SP, Cortaredona S et al (2020) Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios. PLoS ONE 15:e238565
Gurung M, Li Z, You H et al (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590
Gutierrez Lopez DE, Lashinger LM, Weinstock GM et al (2021) Circadian rhythms and the gut microbiome synchronize the host’s metabolic response to diet. Cell Metab 33:873–887
Gutzeit C, Magri G, Cerutti A (2014) Intestinal IgA production and its role in host-microbe interaction. Immunol Rev 260:76–85
Hall KD, Farooqi IS, Friedman JM et al (2022) The energy balance model of obesity: beyond calories in, calories out. Am J Clin Nutr 115:1243–1254
Hild B, Dreier MS, Oh JH et al (2021) Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity. Nat Metab 3:1042–1057
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1273
The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
Koeth RA, Lam-Galvez BR, Kirsop J et al (2019) l‑carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest 129:373–387
Li R, Andreu-Sanchez S, Kuipers F et al (2021) Gut microbiome and bile acids in obesity-related diseases. Best Pract Res Clin Endocrinol Metab 35:101493
Ma C, Han M, Heinrich B et al (2018) Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360(6391):eaan5931. https://doi.org/10.1126/science.aan5931
Malard F, Dore J, Gaugler B et al (2021) Introduction to host microbiome symbiosis in health and disease. Mucosal Immunol 14:547–554
Mcloughlin K, Schluter J, Rakoff-Nahoum S et al (2016) Host selection of microbiota via differential adhesion. Cell Host Microbe 19:550–559
Napolitano M, Covasa M (2020) Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives. Front Microbiol 11:590370
Parada Venegas D, De la Fuente MK, Landskron G et al (2019) Short chain fatty acids (SCFas)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277
Sato FT, Yap YA, Crisma AR et al (2020) Tributyrin attenuates metabolic and inflammatory changes associated with obesity through a GPR109A-dependent mechanism. Cells 9(9):2007. https://doi.org/10.3390/cells9092007
Schluter J, Foster KR (2012) The evolution of mutualism in gut microbiota via host epithelial selection. PLoS Biol 10:e1001424
Shen X, Li L, Sun Z et al (2021) Gut microbiota and atherosclerosis-focusing on the plaque stability. Front Cardiovasc Med 8:668532
Sonnenburg ED, Smits SA, Tikhonov M et al (2016) Diet-induced extinctions in the gut microbiota compound over generations. Nature 529:212–215
Sonnenburg JL, Sonnenburg ED (2019) Vulnerability of the industrialized microbiota. Science 366(6464):eaaw9255
Stacy A, Andrade-Oliveira V, Mcculloch JA et al (2021) Infection trains the host for microbiota-enhanced resistance to pathogens. Cell 184:615–627.e17
Tanoue T, Honda K (2012) Induction of Treg cells in the mouse colonic mucosa: a central mechanism to maintain host-microbiota homeostasis. Semin Immunol 24:50–57
Thaiss CA, Levy M, Korem T et al (2016) Microbiota diurnal rhythmicity programs host transcriptome oscillations. Cell 167:1495–1510.e12
Thevaranjan N, Puchta A, Schulz C et al (2017) Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21:455–466.e4
Tierney BT, Tan Y, Yang Z et al (2022) Systematically assessing microbiome-disease associations identifies drivers of inconsistency in metagenomic research. PLoS Biol 20:e3001556
Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031
Turnbaugh PJ, Ridaura VK, Faith JJ et al (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1:6ra14
Vrang N, Madsen AN, Tang-Christensen M et al (2006) PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 291:R367–375
Zeevi D, Korem T, Zmora N et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094
Zeng MY, Inohara N, Nunez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10:18–26
Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492–506
Zietak M, Kovatcheva-Datchary P, Markiewicz LH et al (2016) Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metab 23:1216–1223
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Hild gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Dagmar Führer-Sakel, Essen
Martin Reincke, München
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Hild, B. Mikrobiom und metabolisches Syndrom – ein Henne-Ei-Problem?. Innere Medizin 64, 649–654 (2023). https://doi.org/10.1007/s00108-023-01531-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-023-01531-z
Schlüsselwörter
- Gastrointestinales Mikrobiom
- Mikrobiommodulation
- Metabolisches Syndrom/Pathogenese
- Dysbiose
- Energiehaushalt